Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  Hsp90 inhibitor SNX-5422 mesylate
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: SNX-5422-CLN1-012, NCI-2017-00260, NCT02973399
Start Over